SCHEMBL31091663

SCHEMBL31091663

CS(=O)(=O)OCC12CCC(CN(Cc3ccccc3)C1)N2Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 2/20 0.41
TSHR P16473 2/20 0.41
RECQL P46063 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTR2A P28223 1/20 0.39
CHRM3 P20309 3/20 0.37
CHRM2 P08172 2/20 0.37
GAA P10253 1/20 0.36
USP2 O75604 2/20 0.36
DRD2 P14416 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25566962 0.84 ACHE (0.39) CYP2D6MEN1KMT2ACHRM3CHRM2
SCHEMBL25566735 0.83 ACHE (0.38) CHRM3CHRM2GAADRD2ACHE
SCHEMBL25566734 0.78 FUCA1 (0.42) CHRM3CHRM2DRD2ALDH1A1
SCHEMBL25566966 0.77 CYP2D6 (0.42) CYP2D6CHRM3CHRM2GAAALDH1A1
SCHEMBL25566965 0.77 CHRM3 (0.43) MEN1KMT2ATSHRCHRM3CHRM2
SCHEMBL25566963 0.75 KDM1A (0.47) CHRM3CHRM2DRD2
SCHEMBL29937525 0.74 CHRM3 (0.42) CYP2D6MEN1KMT2ACHRM3CHRM2
SCHEMBL16197363 0.73 CYP2D6 (0.52) CYP2D6MEN1KMT2ACYP3A4TSHR
SCHEMBL29937437 0.73 CHRM3 (0.41) CYP2D6MEN1KMT2ACHRM3CHRM2
SCHEMBL29936728 0.73 KMT2A (0.43) CYP2D6KMT2ACHRM3CHRM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4442686-A1 KRAS INHIBITORS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd (CN) 2024-10-09 EP disclosed